PRGO

PRGO

USD

Perrigo Company plc Ordinary Shares

$25.220+0.310 (1.244%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Iirimaa

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$24.910

Kõrge

$25.300

Madal

$24.590

Maht

0.21M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

3.4B

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

Ireland

Kauplemisstatistika

Keskmine maht

1.69M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $23.14Praegune $25.220Kõrge $33.46

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 24. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

PRGO (Perrigo Company plc Ordinary Shares): What's Happening and What to Watch

Stock Symbol: PRGO Generate Date: 2025-04-24 23:28:45

Alright, let's break down what's been going on with Perrigo stock lately, looking at the news, how the price has moved, and what some automated systems are predicting. Think of this as getting the lowdown on the situation.

Recent News Buzz

So, what's the latest chatter about Perrigo? We've got two main things popping up.

First off, the company itself announced they'll be dropping their first quarter 2025 financial results on May 7th. This is pretty standard stuff, but it's a date to circle on the calendar. Earnings reports are always a big deal; they can really shake things up depending on whether the numbers beat expectations or fall short. It's a future catalyst, basically.

The other piece of news is a bit more pointed. JP Morgan, a big investment bank, put out a warning. They're saying that potential tariffs, specifically mentioning Trump tariffs, could hit Perrigo's earnings in the near future. That's definitely a negative point. However, they also added that the company might be able to offset some of that pressure by 2026 through becoming more efficient or raising prices. So, it's a near-term worry with a possibility of things getting better down the road.

Putting the news together, the vibe is a bit mixed, leaning cautious because of that tariff warning. But everyone's also waiting to see what the actual financial results look like in early May.

Checking the Price Action

Now, let's look at what the stock price has actually been doing over the past month or so. If you glance at the chart data, you'll see things got pretty interesting around late February/early March. The stock saw a significant jump, climbing from the mid-$24 range up into the high $28s and even touching $30 briefly. That was a strong move!

But since that peak in early March, the trend has been mostly downwards. The price has pulled back quite a bit, settling back into the $24-$25 area where it was before that big run-up. It's been trading somewhat sideways in this lower range over the last couple of weeks, bouncing around a bit but not making any major moves up or down.

Looking at today's data (April 24th), the price is hovering right around $24.89. The AI prediction for today is flat (0.00%), which seems to match this recent sideways action. For the next couple of days, the AI is predicting small increases: +1.46% tomorrow and +1.82% the day after. So, the AI sees a slight upward nudge coming soon from these levels.

What This Might Suggest & Ideas to Consider

Okay, let's try to make sense of all this.

Based on the recent price pullback and the stock now trading in a tighter range around $24-$25, it looks like the post-March rally has completely faded. The price seems to be finding some kind of floor in this area.

The news about potential tariffs is a clear headwind, something that could definitely weigh on the stock. But the upcoming earnings report is a wild card – good results could potentially counteract the tariff fears, at least temporarily.

The AI prediction, while only looking a couple of days out, suggests a small positive move from here. This aligns somewhat with the stock potentially stabilizing after its recent drop.

Considering the price is near recent lows (relative to the March peak), the AI predicts a slight bump, and some technical indicators mentioned in the recommendation data (like MACD and volume surge around the dip) point to potential buying pressure, the apparent near-term leaning seems cautiously positive for a short-term bounce, despite the tariff concerns and upcoming earnings uncertainty.

If someone were considering getting involved based on this data, a potential entry consideration might be around the current price levels, perhaps in the $24.74 to $24.89 range. Why this area? It's where the stock has been trading recently, it's near a potential support level mentioned in the recommendation ($24.72), and it aligns with the AI's expectation of a slight near-term rise from here.

For managing risk, a potential exit or stop-loss consideration could be placed below recent lows or a key support level. The recommendation data suggests a stop-loss around $22.26. This level is well below the recent trading range and would signal that the current stability has broken down. On the upside, if the stock does bounce, a potential take-profit level could be around $26.30, as suggested by the recommendation. This level is above the recent trading range and could represent capturing a short-term move back towards previous resistance.

Remember, these are just potential ideas based on the provided data points and are about managing the risks involved.

A Little Company Context

Just to keep things in perspective, Perrigo is a company focused on consumer self-care products and specialty generic drugs. They sell things you'd find in a pharmacy or supermarket, like cough medicine, infant formula, pain relievers, and skin care items. This means their business can be affected by consumer spending habits, healthcare trends, and, yes, things like import tariffs, which could impact their costs. The earnings report will give a clearer picture of how these factors are currently playing out for them.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

PR Newswire

Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2025...

Vaata rohkem
Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025
Analyst Upgrades

Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan

JP Morgan warns tariffs could impact Perrigo's near-term earnings, though efficiencies and price hikes may ease pressure by 2026.

Vaata rohkem
Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 28. apr 2025, 07:50

LangevNeutraalneTõusev

61.4% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Väärtus
Kauplemisjuhend

Sisenemispunkt

$25.21

Võta kasum

$25.73

Peata kahjum

$22.71

Põhitegurid

PDI 6.7 on MDI 5.3 kohal ADX-iga 21.9, mis viitab tõusutrendile
Praegune hind on tugitasemele ($25.20) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 8.0x keskmisest (16,251), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0390 on signaalijoone 0.0411 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.